CAVERJECT 20 microgrammes/1 ml, lyophilisat et solution pour usage parentéral — 1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 1 ml avec 2 aiguille(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400933963521
  • CIP7 3396352
  • CIS 68594342

What the source publishes

Holder
PFIZER HOLDING FRANCE
Active ingredients
ALPROSTADIL
Form
lyophilisat et solution pour usage parentéral
Package
1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 1 ml avec 2 aiguille(s)
Routes
intracaverneuse
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
1994-09-30
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400933963521
{
  "cis": "68594342",
  "cip7": "3396352",
  "form": "lyophilisat et  solution pour usage parentéral",
  "name": "CAVERJECT 20 microgrammes/1 ml, lyophilisat et solution pour usage parentéral — 1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 1 ml avec 2 aiguille(s)",
  "cip13": "3400933963521",
  "holder": "PFIZER HOLDING FRANCE",
  "routes": [
    "intracaverneuse"
  ],
  "holders": [
    "PFIZER HOLDING FRANCE"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "9.85",
  "authorisedOn": "1994-09-30",
  "compositions": [
    {
      "name": "ALPROSTADIL",
      "nature": "SA",
      "strength": "20 microgrammes",
      "linkageNumber": "1",
      "substanceCode": "01591",
      "dosageReference": "un lyophilisat",
      "pharmaceuticalElement": "lyophilisat"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "8.83",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "CAVERJECT 20 microgrammes/1 ml, lyophilisat et solution pour usage parentéral",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-18",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 1 ml avec 2 aiguille(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30%"
  ],
  "marketingDeclaredOn": "2026-05-29",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ALPROSTADIL"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400933963521"